For its first fiscal quarter (ending March 31), Boston Scientific Corp (NYSE: BSX) has reported E.P.S. of $0.34 compared to $0.21 a year ago. For the latest four quarters through March 31, E.P.S. were $1.20 compared to $0.59 a year ago.
Recent Price Action
Boston Scientific Corp (NYSE: BSX) stock enjoyed a very large increase of 5.7% on 4/24/24. The shares closed at $72.91. Moreover, this advance was accompanied by exceptionally high trading volume at 246% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 7.0% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, BSX is expected to continue to be a major Value Builder.
Boston Scientific has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Boston Scientific has a poor Appreciation Score of 20 but a good Power Rating of 81, producing the Neutral Value Trend Rating.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment